Friedrich & ClementBETA

Medicinal product with the active substance nilotinib (ATC: L01EA03)

Arzneimittel mit dem Wirkstoff Nilotinib (ATC: L01EA03)

Germany · Magdeburg

Contract

BuyerAOK Sachsen - Anhalt
TypeSupplies
Estimated valuevalue not published
Published18 June 2025
CategoryMedical equipment & pharma · CPV 33600000

Who has won here before

CompanyAwardsPeriod
GlaxoSmithKline GmbH & Co. KG · München52012–2026
Novartis Pharma GmbH · Nürnberg52013–2026
PIK AG52025
Städtische Werke Magdeburg GmbH & Co. KG42025
RpDoc Solutions GmbH · Saarbrücken42026
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.

How often this buyer tenders this

201971
202060
2021100
202287
2023169
2024277
2025392
2026161

Who knows the rhythm prepares instead of reacting.

284
days until the deadlineMonday 31 May at 00:00

How to bid

Read the full noticeOriginal + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →
Friedrich & ClementEuropean public tenders, collected and searchable — 73 portals, 27 countries.Signup, search and the morning edition are available in English. Legal pages are provided in German.
Medicinal product with the active substance nilotinib (ATC: L01EA03) — Friedrich & Clement